Durect Corp Reports Results For The Quarter Ended In December: Earnings Summary

DURECT

27/03/2024 21:01

* DURECT Corp  DRRX.OQ  reported a quarterly adjusted loss
of 10
cents​​ per share for the quarter ended in December, higher than
the same quarter last year, when the company reported EPS of -46
cents.  The mean expectation of four analysts for the quarter
was for a loss of 33 cents per share. Wall Street expected
results to range from -43 cents to -25 cents per share.
    * Revenue fell 19.5% to $2.67 million from a year ago;
analysts
expected $2.48 million. 
    * DURECT Corp's reported EPS for the quarter was a loss
of 10
cents​.
    * The company reported a quarterly loss of $1.44 million.
    * DURECT Corp shares had risen by 115.3% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for DURECT Corp is
$6.75 
This summary was machine generated from LSEG data March 27 at
09:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.33          -0.10          Beat
 Sep. 30 2023      -0.42          -0.14          Beat
 Jun. 30 2023      -0.51          -0.42          Beat
 Mar. 31 2023      -0.53          -0.47          Beat